Fifth Third Bancorp’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.77M Buy
75,907
+51,097
+206% +$3.56M 0.01% 756
2025
Q4
$1.65M Sell
24,810
-112
-0.4% -$7.24K 0.01% 509
2025
Q3
$1.68M Buy
24,922
+646
+3% +$51.1K 0.01% 505
2025
Q2
$2.12M Sell
24,276
-7,380
-23% -$578K 0.01% 454
2025
Q1
$2.16M Buy
31,656
+309
+1% +$25.2K 0.01% 431
2024
Q4
$2.44M Buy
31,347
+5,553
+22% +$411K 0.01% 419
2024
Q3
$1.73M Sell
25,794
-1,547
-6% -$127K 0.01% 501
2024
Q2
$3.1M Sell
27,341
-3,264
-11% -$413K 0.01% 391
2024
Q1
$4.24M Buy
30,605
+5,176
+20% +$651K 0.02% 337
2023
Q4
$3.16M Buy
25,429
+2,894
+13% +$296K 0.01% 378
2023
Q3
$2.1M Sell
22,535
-701
-3% -$79K 0.01% 430
2023
Q2
$2.99M Buy
23,236
+7,002
+43% +$847K 0.01% 389
2023
Q1
$1.89M Sell
16,234
-334
-2% -$37.4K 0.01% 453
2022
Q4
$1.88M Buy
16,568
+1,250
+8% +$137K 0.01% 454
2022
Q3
$1.23M Buy
15,318
+2,053
+15% +$174K 0.01% 503
2022
Q2
$989K Sell
13,265
-903
-6% -$82.4K ﹤0.01% 545
2022
Q1
$1.81M Sell
14,168
-4,432
-24% -$485K 0.01% 474
2021
Q4
$2.5M Buy
18,600
+7,404
+66% +$1.06M 0.01% 435
2021
Q3
$1.53M Buy
11,196
+1,564
+16% +$197K 0.01% 507
2021
Q2
$1.03M Buy
9,632
+1,040
+12% +$99.9K ﹤0.01% 568
2021
Q1
$772K Buy
8,592
+2,644
+44% +$248K ﹤0.01% 601
2020
Q4
$550K Buy
5,948
+176
+3% +$15.7K ﹤0.01% 650
2020
Q3
$595K Buy
5,772
+260
+5% +$27.2K ﹤0.01% 610
2020
Q2
$559K Buy
5,512
+388
+8% +$34.7K ﹤0.01% 610
2020
Q1
$345K Buy
5,124
+1,116
+28% +$69.4K ﹤0.01% 679
2019
Q4
$219K Buy
4,008
+96
+2% +$4.55K ﹤0.01% 917
2019
Q3
$146K Buy
3,912
+560
+17% +$21.8K ﹤0.01% 1001
2019
Q2
$126K Buy
3,352
+820
+32% +$25.8K ﹤0.01% 1058
2019
Q1
$75K Buy
+2,532
New +$89K ﹤0.01% 1155
2017
Q3
Sell
-1,032
Closed -$19K 2213
2017
Q2
$19K Buy
1,032
+116
+13% +$2.14K ﹤0.01% 1557
2017
Q1
$19K Sell
916
-624
-41% -$12.2K ﹤0.01% 1573
2016
Q4
$23K Sell
1,540
-720
-32% -$12.8K ﹤0.01% 1575
2016
Q3
$50K Buy
2,260
+1,716
+315% +$38.2K ﹤0.01% 1325
2016
Q2
$11K Buy
+544
New +$9.26K ﹤0.01% 1772
2015
Q4
Sell
-856
Closed -$18K 2772
2015
Q3
$18K Buy
+856
New +$19.1K ﹤0.01% 1765
2014
Q2
Sell
-1,780
Closed -$18K 2374
2014
Q1
$18K Sell
1,780
-2,824
-61% -$29.2K ﹤0.01% 1822
2013
Q4
$41K Sell
4,604
-8,648
-65% -$68.4K ﹤0.01% 1413
2013
Q3
$93K Buy
+13,252
New +$84K ﹤0.01% 1068

Other funds holding DXCM

Fifth Third Bancorp's DXCM Position: Q1 2026 in Review

Fifth Third Bancorp increased its DexCom (DXCM) stake by 206% in Q1 2026, buying an estimated $3.56M and bringing the position to 75,907 shares worth $4.77M. The position accounts for 0.01% of the portfolio, ranked #756.

Fifth Third Bancorp first reported a position in DXCM in Q3 2013 and has held it in 38 quarters since. 957 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • Fifth Third Bancorp held 75,907 shares of DexCom worth $4.77M as of Q1 2026.
  • Fifth Third Bancorp bought 51,097 DexCom shares in Q1 2026, an estimated $3.56M.
  • DexCom made up 0.01% of Fifth Third Bancorp's portfolio in Q1 2026, its #756 holding.
  • Fifth Third Bancorp first reported a position in DexCom in Q3 2013 and has held it in 38 quarters since.
  • 957 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on Fifth Third Bancorp's 13F filing for Q1 2026, filed 1 May 2026.